apobec3g

APOBEC3G-IN-1 (MN136.0185) is a targeted APOBEC3G inhibitor with anti-HIV activity for the study of infectious diseases and cancer.

TF-3-G-cThea, a marker compound associated with storage in black tea, serves to indicate the quality and condition of the tea during storage.

Nucleoside Derivatives - LNA-related nucleosides; Nucleoside Phosphoramidites

2'-O-Propargyl G(iBu)-3'-phosphoramidite is a Nucleoside Phosphoramidite; Nucleoside Derivative - 2'-Modified nucleoside.

2'-MOE-G(iBu)-3'-phosphoramidite is a Nucleoside Phosphoramidite;Nucleoside Derivative - 2'-Modified nucleoside;.

3'-O-MOE-G(iBu)-2'-phosphoramidite is a Nucleoside Phosphoramidite.

3'-O-Me-G(iBu)-2'-phosphoramidite is a Nucleoside Phosphoramidite.

IMB-301 is a small molecular inhibitor via virtual screening according to the hA3G model.

Vif-A3G Inhibitor N.41 is a HIV-1 inhibitor-targeting drug. It causes Vif-dependent degradation of human APOBEC3G, thereby inhibiting the Vif-A3G interaction.

HIV-1 inhibitor-47 is a compound that effectively inhibits HIV-1 by preventing the vif-dependent degradation of human APOBEC3G. It has a notable inhibition effect, with an IC50 value of 14.33 μM. Additionally, HIV-1 inhibitor-47 is involved in the synthesis of derivatives of 1-(2-pyrimidinyl)piperazine, which have the potential to exhibit antianxiety, antidepressant, and antipsychotic effects [1] [2] [3].

Deaminase inhibitor-1 is an APOBEC3G DNA Deaminase inhibitor with an IC 50 value of 18.9 μM [1].